Exagen (XGN) Retained Earnings (2018 - 2026)

Exagen has reported Retained Earnings for 9 years, with the latest figure at -$318.2 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 6.74% year-over-year to -$318.2 million; the trailing twelve-month figure through Mar 2026 stood at -$318.2 million (down 6.74% YoY), and the FY2025 full-year result was -$314.3 million, down 6.78% from the prior year.
• Retained Earnings for Q1 2026 stood at -$318.2 million, down from -$314.3 million in the prior quarter.
• The five-year high for Retained Earnings was -$218.4 million in Q1 2022, with the low at -$318.2 million in Q1 2026.
• Historically, Retained Earnings has averaged -$278.1 million across 5 years, with a median of -$282.6 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings dropped 22.77% — and 2024, when it declined 5.41%.
• Exagen's Retained Earnings stood at -$255.5 million in 2022, then declined by 9.27% to -$279.2 million in 2023, then fell by 5.41% to -$294.3 million in 2024, then declined by 6.78% to -$314.3 million in 2025, then fell by 1.25% to -$318.2 million in 2026.
• The last three Retained Earnings figures came in at -$318.2 million (Q1 2026), -$314.3 million (Q4 2025), and -$309.6 million (Q3 2025), per Business Quant data.